Search alternatives:
table 11a » table 11, table 1a, table 11.1
table 27 » table 2, table 2a, tabelle 27
table 21 » table 2.1, table 2, table 2a
table b » table c
table 11a » table 11, table 1a, table 11.1
table 27 » table 2, table 2a, tabelle 27
table 21 » table 2.1, table 2, table 2a
table b » table c
|
by Johri, Brij M., Ambegaokar, Kunda B., Srivastava, Prem S.
Published 1992
Table of Contents:
“...Volume 1-2 -- 1 The Background -- 2 Diagnostic Characters -- 3 Developmental Aspects -- 4...”Published 1992
Springer Berlin Heidelberg
|
by Whitlock, Evelyn P., Williams, Selvi, Burda, Brittany U., Feightner, Alisha
Published 2015
“...When restricted to all trials of 100 mg or less, the risk tended to decrease (OR, 1.32 [95% CI...”Published 2015
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Whitlock, Evelyn P., Williams, Selvi, Burda, Brittany U., Feightner, Alisha
Published 2015
“...When restricted to all trials of 100 mg or less, the risk tended to decrease (OR, 1.32 [95% CI...”Published 2015
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Char, Bruce W., Geddes, Keith O., Gonnet, Gaston H., Leong, Benton L.
Published 1991
Table of Contents:
“... -- 10.5 Plots Package -- 10.6 Examples -- 11 Miscellaneous Facilities -- 11.1 Debugging Facilities...”Published 1991
Springer New York